ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Junqueira Of Brazil Named Next UICC President, Murphy Gets Another Term as Secretary General

September 5, 1980

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002